Skip to main content
Signal8

Sachs David C.

SEC insider (Form 3/4/5 filer). CIK 0001848899. Chief Financial Officer at ImmunityBio, Inc. (IBRX). 12 reported Form 4/5 transactions since Sep 2024; latest on Feb 22, 2026. Located in SAN DIEGO, CA.

Companies Sachs David C. has filed insider reports for

  • ImmunityBio, Inc. (IBRX): Officer, Chief Financial Officer
Sachs David C. profile photo

Sachs David C.

CIK: 0001848899

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)5 (41.7%)

Derivative conversions

Awards (A)2 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)5 (41.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ImmunityBio, Inc. logo
IBRX

ImmunityBio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

  • ImmunityBio, Inc. logo
    IBRX

    ImmunityBio, Inc.

    Feb 22, 2026
    Tax Payment
    Direct
    20.7K shares at avg. $8.70$180K
  • ImmunityBio, Inc. logo
    IBRX

    ImmunityBio, Inc.

    Feb 22, 2026
    Exercise
    Direct
    40.7K shares-
  • ImmunityBio, Inc. logo
    IBRX

    ImmunityBio, Inc.

    Feb 10, 2026
    Exercise
    Direct
    82.2K shares-
  • ImmunityBio, Inc. logo
    IBRX

    ImmunityBio, Inc.

    Feb 10, 2026
    Tax Payment
    Direct
    42.6K shares at avg. $6.93$296K
  • ImmunityBio, Inc. logo
    IBRX

    ImmunityBio, Inc.

    Dec 31, 2025
    Exercise
    Direct
    30.4K shares-
  • ImmunityBio, Inc. logo
    IBRX

    ImmunityBio, Inc.

    Dec 31, 2025
    Tax Payment
    Direct
    15.4K shares at avg. $1.98$31K
  • ImmunityBio, Inc. logo
    IBRX

    ImmunityBio, Inc.

    Feb 22, 2025
    Tax Payment
    Direct
    15.9K shares at avg. $3.42$54K
  • ImmunityBio, Inc. logo
    IBRX

    ImmunityBio, Inc.

    Feb 22, 2025
    Exercise
    Direct
    40.7K shares-
  • ImmunityBio, Inc. logo
    IBRX

    ImmunityBio, Inc.

    Feb 10, 2025
    Award

    Restricted Stock Units

    Direct
    246.7K shares-
  • ImmunityBio, Inc. logo
    IBRX

    ImmunityBio, Inc.

    Feb 10, 2025
    Award

    Stock Option (right to buy)

    Direct
    843.8K shares-

1-10 of 12